{"id":113967,"date":"2021-05-14T17:00:00","date_gmt":"2021-05-14T17:00:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2870865"},"modified":"2021-05-14T17:00:00","modified_gmt":"2021-05-14T17:00:00","slug":"frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2021\/05\/14\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/","title":{"rendered":"Frontotemporal Dementia Market Insights, Epidemiology, Treatment Landscape, Emerging Drugs and Leading Companies"},"content":{"rendered":"<p><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-new20logo-01-2.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"\" loading=\"lazy\" style=\"display: block; margin-bottom: 5px; clear:both;max-width: 100%;\" link_thumbnail=\"\" \/><\/p>\n<p><span style=\"font-weight: 400;\"><img decoding=\"async\" style=\"display: block; margin-left: auto; margin-right: auto;\" src=\"http:\/\/beta-kiosk.icrowdnewswire.com\/assets\/source\/users\/delveinsight\/Frontotemporal%20Dementia%20Market%20Insights-01-01.jpg?1620967646473\" alt=\"Frontotemporal Dementia Market Insights-01-01\" \/><\/span><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><a href=\"https:\/\/www.delveinsight.com\/sample-request\/frontotemporal-dementia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Frontotemporal Dementia Market Insights<\/strong><\/a><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Hypovolemic Shock, historical and forecasted epidemiology as well as the Hypovolemic Shock market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><strong>Some of the Key Highlights from the <\/strong><a href=\"https:\/\/www.delveinsight.com\/sample-request\/frontotemporal-dementia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Frontotemporal Dementia Market Report<\/strong><\/a><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">As per the study conducted by E. Ratnavalli et al. 2002, the prevalence of early-onset Frontotemporal Dementia and Alzheimer&rsquo;s disease were the same which was estimated to be <\/span><strong>15 per 100,000<\/strong><span style=\"font-weight: 400;\"> in the 45- to 64-year-old population. The mean age at onset of Frontotemporal Dementia was 52.8 years and there was a striking male preponderance.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">According to Chiadikaobi U Onyike et al. Point prevalence was projected to be <\/span><strong>15&ndash;22 per 100,000<\/strong><span style=\"font-weight: 400;\">, with a prevalence of <\/span><strong>2.7&ndash;4.1 per 100,000.<\/strong><span style=\"font-weight: 400;\"> Around a quarter of the cases begin later in life.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">According to a study conducted by Juan Joseph Young et al. in 2017, the prevalence of FTD in people aged 45 to 65 years ranged from <\/span><strong>15 to 22 per 100,000<\/strong><span style=\"font-weight: 400;\"> people in the United States, with incidence rates ranging from <\/span><strong>2.7 to 4.1 per 100,000<\/strong><span style=\"font-weight: 400;\"> in the same age group.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Key Pipeline Therapies in the Frontotemporal Dementia market include <\/span><strong>LMTX <\/strong><span style=\"font-weight: 400;\">(TauRx Therapeutics)<\/span><strong> and AL001 <\/strong><span style=\"font-weight: 400;\">(Alector).<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Major companies involved in the Frontotemporal Dementia market are <\/span><strong>TauRx Therapeutics, Alector, <\/strong><span style=\"font-weight: 400;\">among others.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">The increase in FTD Market Size is a direct consequence of the increasing prevalent population of Frontotemporal Dementia patients in the 7MM.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Visit to learn more @ <\/span><a href=\"https:\/\/www.delveinsight.com\/sample-request\/frontotemporal-dementia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Frontotemporal Dementia Market Analysis and Forecast<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">The <\/span><a href=\"https:\/\/www.delveinsight.com\/sample-request\/frontotemporal-dementia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Frontotemporal Dementia market report<\/strong><\/a><span style=\"font-weight: 400;\"> provides current treatment practices, emerging drugs, Frontotemporal Dementia market share of the individual therapies, current and forecasted Frontotemporal Dementia market size during the study period of 2017-30 in the 7MM (the US, EU5 (the UK, Germany, Italy, Spain and France), and Japan).<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/blog\/frontotemporal-dementia-market\/?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Frontotemporal Dementia: Disease Overview<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Frontotemporal Dementia (FTD) is a broad term that refers to a variety of rare brain disorders that mainly affect the frontal and temporal lobes. Parts of these lobes shrink in this disorder (atrophy). The presence of proteins TDP43 and tau, which specifically causes damage to the temporal and frontal lobes of the brain, is the primary cause of frontotemporal lobe degeneration.<\/span><\/p>\n<p><strong>Frontotemporal Dementia Epidemiology Segmentation<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">The Frontotemporal Dementia report proffers epidemiological analysis for the study period 2017-30 in the 7MM segmented into:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Frontotemporal Dementia Prevalence<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Frontotemporal Dementia Gender-Specific Prevalent Cases<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Frontotemporal Dementia Age-Specific Prevalent Cases<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Frontotemporal Dementia Diagnosed and Treatable Cases<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">To know more about epidemiology visit, <\/span><a href=\"https:\/\/www.delveinsight.com\/sample-request\/frontotemporal-dementia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Frontotemporal Dementia Epidemiology<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/blog\/frontotemporal-dementia-market\/?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Frontotemporal Dementia Treatment Landscape<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">There is currently no targeted therapy for the cure of Frontotemporal Dementia (FTD), although certain symptomatic therapies are provided to patients with Frontotemporal Dementia.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The major treatment options in the FTD therapy market are:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Antidepressants Drugs (fluoxetine, fluvoxamine, sertraline, paroxetine, citalopram, bupropion, and mirtazapine)<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Antipsychotic Medications (olanzapine or quetiapine)<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Speech and Language Therapy<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Occupational Therapy<\/span><\/li>\n<\/ul>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/frontotemporal-dementia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Frontotemporal Dementia Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Leading pharmaceutical companies including TauRx Therapeutics, Alector, and others are expected to enter the Frontotemporal Dementia market with new therapies.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The introduction of LMTX (TauRx Therapeutics) and AL001 (Alector) is expected to give the Frontotemporal Dementia market a significant boost in the forecast period 2017-30 in the 7MM.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Furthermore, extensive R&amp;D in the domain, as well as increasing Frontotemporal Dementia prevalence, are driving the Frontotemporal Dementia market forward.<\/span><\/p>\n<p><strong>Frontotemporal Dementia Emerging Therapies and Leading Companies<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">LMTX: TauRx Therapeutics<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">AL001: Alector<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Know more about emerging therapies and companies @ <\/span><a href=\"https:\/\/www.delveinsight.com\/sample-request\/frontotemporal-dementia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Frontotemporal Dementia Emerging Therapies and Leading Companies<\/strong><\/a><\/p>\n<p><strong>Table of Content:<\/strong><\/p>\n<table style=\"border-collapse: collapse; width: 100%;\" border=\"1\">\n<tbody>\n<tr style=\"height: 17px;\">\n<td style=\"width: 11.1765%; height: 17px;\">1.<\/td>\n<td style=\"width: 88.8235%; height: 17px;\"><span style=\"font-weight: 400;\">Report Introduction<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 11.1765%; height: 17px;\">2.<\/td>\n<td style=\"width: 88.8235%; height: 17px;\"><span style=\"font-weight: 400;\">Frontotemporal Dementia: Market Overview at a Glance<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 11.1765%; height: 17px;\">3.<\/td>\n<td style=\"width: 88.8235%; height: 17px;\"><span style=\"font-weight: 400;\">Disease Background and Overview: Frontotemporal Dementia<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 11.1765%; height: 17px;\">4.<\/td>\n<td style=\"width: 88.8235%; height: 17px;\"><span style=\"font-weight: 400;\">Epidemiology and Patient Population<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 11.1765%; height: 17px;\">5.<\/td>\n<td style=\"width: 88.8235%; height: 17px;\"><span style=\"font-weight: 400;\">Frontotemporal Dementia: Country-Wise Epidemiology<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 11.1765%; height: 17px;\">6.<\/td>\n<td style=\"width: 88.8235%; height: 17px;\"><span style=\"font-weight: 400;\">United States Epidemiology<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 11.1765%; height: 17px;\">7.<\/td>\n<td style=\"width: 88.8235%; height: 17px;\"><span style=\"font-weight: 400;\">EU&ndash;5 Countries Epidemiology<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 11.1765%; height: 17px;\">8.<\/td>\n<td style=\"width: 88.8235%; height: 17px;\"><span style=\"font-weight: 400;\">Japan Epidemiology<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 11.1765%; height: 17px;\">9.<\/td>\n<td style=\"width: 88.8235%; height: 17px;\"><span style=\"font-weight: 400;\">Frontotemporal Dementia: Treatments and Medical Practices<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 11.1765%; height: 17px;\">10.<\/td>\n<td style=\"width: 88.8235%; height: 17px;\"><span style=\"font-weight: 400;\">Emerging Therapies<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 11.1765%; height: 17px;\">11.<\/td>\n<td style=\"width: 88.8235%; height: 17px;\"><span style=\"font-weight: 400;\">Key Cross Competition<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 11.1765%; height: 17px;\">12.<\/td>\n<td style=\"width: 88.8235%; height: 17px;\"><span style=\"font-weight: 400;\">Frontotemporal Dementia Market Size<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 11.1765%; height: 17px;\">13.<\/td>\n<td style=\"width: 88.8235%; height: 17px;\"><span style=\"font-weight: 400;\">7MM Frontotemporal Dementia: Country-Wise Market Analysis<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 11.1765%; height: 17px;\">14.<\/td>\n<td style=\"width: 88.8235%; height: 17px;\"><span style=\"font-weight: 400;\">United States Market Size<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 11.1765%; height: 17px;\">15.<\/td>\n<td style=\"width: 88.8235%; height: 17px;\"><span style=\"font-weight: 400;\">EU5 Market Size<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 11.1765%; height: 17px;\">16.<\/td>\n<td style=\"width: 88.8235%; height: 17px;\"><span style=\"font-weight: 400;\">Japan Market Size<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 11.1765%; height: 17px;\">17.<\/td>\n<td style=\"width: 88.8235%; height: 17px;\"><span style=\"font-weight: 400;\">Report Methodology<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 11.1765%; height: 17px;\">18.<\/td>\n<td style=\"width: 88.8235%; height: 17px;\"><span style=\"font-weight: 400;\">DelveInsight Capabilities<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 11.1765%; height: 17px;\">19.<\/td>\n<td style=\"width: 88.8235%; height: 17px;\"><span style=\"font-weight: 400;\">Disclaimer<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 11.1765%; height: 17px;\">20.<\/td>\n<td style=\"width: 88.8235%; height: 17px;\"><span style=\"font-weight: 400;\">About DelveInsight<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Know more what&rsquo;s covered in the <a href=\"https:\/\/www.delveinsight.com\/sample-request\/frontotemporal-dementia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Frontotemporal Dementia Market Assessment Report<\/strong><\/a> <strong>&nbsp;<\/strong><\/p>\n<p><strong>Related Reports<\/strong><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/familial-chylomicronemia-syndrome-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Familial Chylomicronemia Syndrome<\/strong><strong> Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Get comprehensive historical and forecast analysis of <\/span><span style=\"font-weight: 400;\">Familial Chylomicronemia Syndrome<\/span><span style=\"font-weight: 400;\"> Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><strong>Ionis Pharmaceuticals, Arrowhead Pharmaceuticals, Novelion Therapeutics<\/strong><span style=\"font-weight: 400;\">, among others.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/intrahepatic-cholangiocarcinoma-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Intrahepatic Cholangiocarcinoma<\/strong><strong> Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Get comprehensive historical and forecast analysis of <\/span><span style=\"font-weight: 400;\">Intrahepatic Cholangiocarcinoma<\/span><span style=\"font-weight: 400;\"> Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><strong>Incyte Corporation,&nbsp; Roche, Delcath Systems, Basilea Pharmaceutica, Agios Pharmaceuticals, Bayer, Qed Therapeutics,<\/strong><span style=\"font-weight: 400;\"> among others.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/lamellar-ichthyosis-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Lamellar Ichthyosis<\/strong><strong> Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Get comprehensive historical and forecast analysis of <\/span><span style=\"font-weight: 400;\">Lamellar Ichthyosis<\/span><span style=\"font-weight: 400;\"> Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><strong>Timber Pharmaceuticals, Krystal Biotech, Galderma<\/strong><span style=\"font-weight: 400;\"> among others.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/dementia-with-diabetes-market-forecast?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Dementia with Diabetes Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Get comprehensive historical and forecast analysis of <\/span><span style=\"font-weight: 400;\">Dementia with Diabetes<\/span><span style=\"font-weight: 400;\"> Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><strong>Novo Nordisk, vTv Therapeutics,<\/strong><span style=\"font-weight: 400;\"> among others.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/lewy-body-dementia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Lewy Body Dementia Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Lewy Body Dementia Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Lewy Body Dementia, historical and forecasted epidemiology as well as the Lewy Body Dementia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/vascular-dementia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Vascular Dementia Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Vascular Dementia Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Vascular Dementia, historical and forecasted epidemiology as well as the Vascular Dementia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/chronic-inflammatory-demyelinating-polyradiculoneuropathy-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Chronic Inflammatory Demyelinating Polyradiculoneuropathy Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Chronic Inflammatory Demyelinating Polyradiculoneuropathy &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Chronic Inflammatory Demyelinating Polyradiculoneuropathy , historical and forecasted epidemiology as well as the Chronic Inflammatory Demyelinating Polyradiculoneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/atopic-dermatitis-ad-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Atopic Dermatitis Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Atopic Dermatitis Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Atopic Dermatitis, historical and forecasted epidemiology as well as the Atopic Dermatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/fragile-x-syndrome-fxs-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Fragile X Syndrome Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Get comprehensive historical and forecast analysis of <\/span><span style=\"font-weight: 400;\">Fragile X Syndrome<\/span><span style=\"font-weight: 400;\"> Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><strong>Neuren Pharmaceuticals, Ovid Therapeutics, Tetra Therapeutics,&nbsp; Confluence Pharmaceuticals, Zynerba Pharmaceuticals,<\/strong><span style=\"font-weight: 400;\"> among others.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/friedreichs-ataxia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Friedreich&#8217;s Ataxia Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Friedreich&#8217;s Ataxia &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Friedreich&#8217;s Ataxia, historical and forecasted epidemiology as well as the Friedreich&#8217;s Ataxia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/blog\/?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Get in touch with our Business Executive @ Rare disease market insights to know more.&nbsp;<\/strong><\/a><\/p>\n<p><strong>About<\/strong><a href=\"https:\/\/www.delveinsight.com\/?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"> <strong>DelveInsight<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.&nbsp;<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform<\/span><a href=\"https:\/\/www.pharmdelve.com\/?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"> <strong>PharmDelve<\/strong><span style=\"font-weight: 400;\">.<\/span><\/a><\/p>\n<p><strong>Contact Us&nbsp;<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Sandeep Joshi&nbsp;<\/span><\/p>\n<p><span style=\"font-weight: 400;\">info@delveinsight.com&nbsp;<\/span><\/p>\n<p><span style=\"font-weight: 400;\">+1(919)321-6187&nbsp;<\/span><\/p>\n<p><a href=\"http:\/\/www.delveinsight.com\"><span style=\"font-weight: 400;\">www.delveinsight.com<\/span><\/a><\/p>\n<p><strong>Connect With Us at:<\/strong><\/p>\n<p><a href=\"https:\/\/www.linkedin.com\/company\/delveinsight-business-research-llp\/\"><strong>LinkedIn<\/strong><\/a> <strong>|<\/strong><a href=\"https:\/\/www.facebook.com\/delveinsightindia\/\"> <strong>Facebook<\/strong><\/a> <strong>|<\/strong><a href=\"https:\/\/twitter.com\/delve_insight\"> <strong>Twitter<\/strong><\/a><\/p>\n<p class=\"tags\">Tags: <a href=\"https:\/\/icrowdnewswire.com\/tag\/frontotemporaldementiamarkettrends\/\" rel=\"tag\">FrontotemporalDementiaMarketTrends<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/frontotemporaldementiamajorplayers\/\" rel=\"tag\">FrontotemporalDementiaMajorPlayers<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/frontotemporaldementiapipelinetherapies\/\" rel=\"tag\">FrontotemporalDementiaPipelineTherapies<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/frontotemporaldementiadisease\/\" rel=\"tag\">FrontotemporalDementiaDisease<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/frontotemporaldementiamarketsize\/\" rel=\"tag\">FrontotemporalDementiaMarketSize<\/a> <\/p>\n<div><strong>See Campaign: <\/strong><a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.delveinsight.com\/<\/a><br \/><b>Contact Information:<\/b><br \/>Sandeep Joshi\u00a0 info@delveinsight.com\u00a0 +1(919)321-6187\u00a0 <\/p>\n<p><b>Tags:<\/b><br \/><a href=\"\"><\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/reportedtimes\/\" rel=\"category tag\">Reportedtimes<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/ips\/\" rel=\"category tag\">IPS<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/menafn\/\" rel=\"category tag\">Menafn<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/extended-distribution\/\" rel=\"category tag\">Extended Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/icn-internal-distribution\/\" rel=\"category tag\">iCN Internal Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/research-newswire\/\" rel=\"category tag\">Research Newswire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/language\/english\/\" rel=\"category tag\">English<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"\" alt=\"image\" width=\"400\" height=\"300\" class=\"cwdfimg\" \/><\/div>\n<div>\n<h3>Contact Information:<\/h3>\n<p>Sandeep Joshi\u00a0<br \/> info@delveinsight.com\u00a0<br \/> +1(919)321-6187\u00a0 <\/p>\n<\/p>\n<\/div>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/\">Frontotemporal Dementia Market Insights, Epidemiology, Treatment Landscape, Emerging Drugs and Leading Companies<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\">Financial Market Brief<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight&rsquo;s Frontotemporal Dementia Market Insights report delivers an in-depth understanding of the Hypovolemic Shock, historical and forecasted epidemiology as well as the Hypovolemic Shock market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of the Key Highlights from the Frontotemporal Dementia Market Report As per the study [&hellip;]<\/p>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/\">Frontotemporal Dementia Market Insights, Epidemiology, Treatment Landscape, Emerging Drugs and Leading Companies<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/\">Financial Market Brief<\/a>.<\/p>\n<p> <a href=\"https:\/\/ipsnews.net\/business\/2021\/05\/14\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":291,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-113967","post","type-post","status-publish","format-standard","hentry","category-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Frontotemporal Dementia Market Insights, Epidemiology, Treatment Landscape, Emerging Drugs and Leading Companies - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipsnews.net\/business\/2021\/05\/14\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Frontotemporal Dementia Market Insights, Epidemiology, Treatment Landscape, Emerging Drugs and Leading Companies - Business\" \/>\n<meta property=\"og:description\" content=\"DelveInsight&rsquo;s Frontotemporal Dementia Market Insights report delivers an in-depth understanding of the Hypovolemic Shock, historical and forecasted epidemiology as well as the Hypovolemic Shock market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of the Key Highlights from the Frontotemporal Dementia Market Report As per the study [&hellip;] The post Frontotemporal Dementia Market Insights, Epidemiology, Treatment Landscape, Emerging Drugs and Leading Companies appeared first on Financial Market Brief. Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipsnews.net\/business\/2021\/05\/14\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-14T17:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-new20logo-01-2.png\" \/>\n<meta name=\"author\" content=\"iCrowdNewswire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"iCrowdNewswire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/05\/14\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/\",\"url\":\"https:\/\/ipsnews.net\/business\/2021\/05\/14\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/\",\"name\":\"Frontotemporal Dementia Market Insights, Epidemiology, Treatment Landscape, Emerging Drugs and Leading Companies - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/05\/14\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/05\/14\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-new20logo-01-2.png\",\"datePublished\":\"2021-05-14T17:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\"},\"breadcrumb\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/05\/14\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ipsnews.net\/business\/2021\/05\/14\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/05\/14\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/#primaryimage\",\"url\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-new20logo-01-2.png\",\"contentUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-new20logo-01-2.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/05\/14\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Frontotemporal Dementia Market Insights, Epidemiology, Treatment Landscape, Emerging Drugs and Leading Companies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\",\"name\":\"iCrowdNewswire\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"caption\":\"iCrowdNewswire\"},\"sameAs\":[\"https:\/\/heymuse.com\/ips\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Frontotemporal Dementia Market Insights, Epidemiology, Treatment Landscape, Emerging Drugs and Leading Companies - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipsnews.net\/business\/2021\/05\/14\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/","og_locale":"en_US","og_type":"article","og_title":"Frontotemporal Dementia Market Insights, Epidemiology, Treatment Landscape, Emerging Drugs and Leading Companies - Business","og_description":"DelveInsight&rsquo;s Frontotemporal Dementia Market Insights report delivers an in-depth understanding of the Hypovolemic Shock, historical and forecasted epidemiology as well as the Hypovolemic Shock market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of the Key Highlights from the Frontotemporal Dementia Market Report As per the study [&hellip;] The post Frontotemporal Dementia Market Insights, Epidemiology, Treatment Landscape, Emerging Drugs and Leading Companies appeared first on Financial Market Brief. Continue Reading &rarr;","og_url":"https:\/\/ipsnews.net\/business\/2021\/05\/14\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/","og_site_name":"Business","article_published_time":"2021-05-14T17:00:00+00:00","og_image":[{"url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-new20logo-01-2.png","type":"","width":"","height":""}],"author":"iCrowdNewswire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"iCrowdNewswire","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ipsnews.net\/business\/2021\/05\/14\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/","url":"https:\/\/ipsnews.net\/business\/2021\/05\/14\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/","name":"Frontotemporal Dementia Market Insights, Epidemiology, Treatment Landscape, Emerging Drugs and Leading Companies - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ipsnews.net\/business\/2021\/05\/14\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/#primaryimage"},"image":{"@id":"https:\/\/ipsnews.net\/business\/2021\/05\/14\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/#primaryimage"},"thumbnailUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-new20logo-01-2.png","datePublished":"2021-05-14T17:00:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee"},"breadcrumb":{"@id":"https:\/\/ipsnews.net\/business\/2021\/05\/14\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipsnews.net\/business\/2021\/05\/14\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/2021\/05\/14\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/#primaryimage","url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-new20logo-01-2.png","contentUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-new20logo-01-2.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ipsnews.net\/business\/2021\/05\/14\/frontotemporal-dementia-market-insights-epidemiology-treatment-landscape-emerging-drugs-and-leading-companies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"Frontotemporal Dementia Market Insights, Epidemiology, Treatment Landscape, Emerging Drugs and Leading Companies"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee","name":"iCrowdNewswire","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","caption":"iCrowdNewswire"},"sameAs":["https:\/\/heymuse.com\/ips"],"url":"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/113967","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/291"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=113967"}],"version-history":[{"count":1,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/113967\/revisions"}],"predecessor-version":[{"id":113968,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/113967\/revisions\/113968"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=113967"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=113967"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=113967"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}